Data on death rates for suicide, by selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time. SOURCE: NCHS, National Vital Statistics System (NVSS); Grove RD, Hetzel AM. Vital statistics rates in the United States, 1940–1960. National Center for Health Statistics. 1968; numerator data from NVSS annual public-use Mortality Files; denominator data from U.S. Census Bureau national population estimates; and Murphy SL, Xu JQ, Kochanek KD, Arias E, Tejada-Vera B. Deaths: Final data for 2018. National Vital Statistics Reports; vol 69 no 13. Hyattsville, MD: National Center for Health Statistics. 2021. Available from: https://www.cdc.gov/nchs/products/nvsr.htm. For more information on the National Vital Statistics System, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

Final counts of deaths by the week the deaths occurred, by state of occurrence, and by select causes of death for 2014-2019. Death counts in this dataset were derived from the National Vital Statistics System database that provides the most timely access to the data. Therefore, counts may differ slightly from final data due to differences in processing, recoding, and imputation.

Data on drug overdose death rates, by drug type and selected population characteristics. Please refer to the PDF or Excel version of this table in the HUS 2019 Data Finder (https://www.cdc.gov/nchs/hus/contents2019.htm) for critical information about measures, definitions, and changes over time. SOURCE: NCHS, National Vital Statistics System, numerator data from annual public-use Mortality Files; denominator data from U.S. Census Bureau national population estimates; and Murphy SL, Xu JQ, Kochanek KD, Arias E, Tejada-Vera B. Deaths: Final data for 2018. National Vital Statistics Reports; vol 69 no 13. Hyattsville, MD: National Center for Health Statistics.2021. Available from: https://www.cdc.gov/nchs/products/nvsr.htm. For more information on the National Vital Statistics System, see the corresponding Appendix entry at https://www.cdc.gov/nchs/data/hus/hus19-appendix-508.pdf.

This dataset contains counts of deaths for California counties based on information entered on death certificates. Final counts are derived from static data and include out-of-state deaths to California residents, whereas provisional counts are derived from incomplete and dynamic data. Provisional counts are based on the records available when the data was retrieved and may not represent all deaths that occurred during the time period. Deaths involving injuries from external or environmental forces, such as accidents, homicide and suicide, often require additional investigation that tends to delay certification of the cause and manner of death. This can result in significant under-reporting of these deaths in provisional data.

The final data tables include both deaths that occurred in each California county regardless of the place of residence (by occurrence) and deaths to residents of each California county (by residence), whereas the provisional data table only includes deaths that occurred in each county regardless of the place of residence (by occurrence). The data are reported as totals, as well as stratified by age, gender, race-ethnicity, and death place type. Deaths due to all causes (ALL) and selected underlying cause of death categories are provided. See temporal coverage for more information on which combinations are available for which years.

The cause of death categories are based solely on the underlying cause of death as coded by the International Classification of Diseases. The underlying cause of death is defined by the World Health Organization (WHO) as "the disease or injury which initiated the train of events leading directly to death, or the circumstances of the accident or violence which produced the fatal injury." It is a single value assigned to each death based on the details as entered on the death certificate. When more than one cause is listed, the order in which they are listed can affect which cause is coded as the underlying cause. This means that similar events could be coded with different underlying causes of death depending on variations in how they were entered. Consequently, while underlying cause of death provides a convenient comparison between cause of death categories, it may not capture the full impact of each cause of death as it does not always take into account all conditions contributing to the death.

Death counts by age, sex, and week for years 2018-2020. Data for 2018 and 2019 are final. Data for 2020 are provisional.

In 2023, there were approximately 750.5 deaths by all causes per 100,000 inhabitants in the United States. This statistic shows the death rate for all causes in the United States between 1950 and 2023. Causes of death in the U.S. Over the past decades, chronic conditions and non-communicable diseases have come to the forefront of health concerns and have contributed to major causes of death all over the globe. In 2022, the leading cause of death in the U.S. was heart disease, followed by cancer. However, the death rates for both heart disease and cancer have decreased in the U.S. over the past two decades. On the other hand, the number of deaths due to Alzheimer’s disease – which is strongly linked to cardiovascular disease- has increased by almost 141 percent between 2000 and 2021. Risk and lifestyle factors Lifestyle factors play a major role in cardiovascular health and the development of various diseases and conditions. Modifiable lifestyle factors that are known to reduce risk of both cancer and cardiovascular disease among people of all ages include smoking cessation, maintaining a healthy diet, and exercising regularly. An estimated two million new cases of cancer in the U.S. are expected in 2025.

The COVID-19 pandemic increased the global death rate, reaching *** in 2021, but had little to no significant impact on birth rates, causing population growth to dip slightly. On a global level, population growth is determined by the difference between the birth and death rates, known as the rate of natural change. On a national or regional level, migration also affects population change. Ongoing trends Since the middle of the 20th century, the global birth rate has been well above the global death rate; however, the gap between these figures has grown closer in recent years. The death rate is projected to overtake the birth rate in the 2080s, which means that the world's population will then go into decline. In the future, death rates will increase due to ageing populations across the world and a plateau in life expectancy. Why does this change? There are many reasons for the decline in death and birth rates in recent decades. Falling death rates have been driven by a reduction in infant and child mortality, as well as increased life expectancy. Falling birth rates were also driven by the reduction in child mortality, whereby mothers would have fewer children as survival rates rose - other factors include the drop in child marriage, improved contraception access and efficacy, and women choosing to have children later in life.

National provisional drug overdose deaths by month and 2013 NCHS Urban–Rural Classification Scheme for Counties. Drug overdose deaths are identified using underlying cause-of-death codes from the Tenth Revision of ICD (ICD–10): X40–X44 (unintentional), X60–X64 (suicide), X85 (homicide), and Y10–Y14 (undetermined). Deaths are based on the county of residence in the United States. Death counts provided are for “12-month ending periods,” defined as the number of deaths occurring in the 12-month period ending in the month indicated. Estimates for 2020 are based on provisional data. Estimates for 2018 and 2019 are based on final data. For more information on NCHS urban-rural classification, see: https://www.cdc.gov/nchs/data/series/sr_02/sr02_166.pdf

This data visualization presents county-level provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. County-level provisional counts include deaths occurring within the 50 states and the District of Columbia, as of the date specified and may not include all deaths that occurred during a given time period. Provisional counts are often incomplete and causes of death may be pending investigation resulting in an underestimate relative to final counts (see Technical Notes).

The provisional data presented on the dashboard below include reported 12 month-ending provisional counts of death due to drug overdose by the decedent’s county of residence and the month in which death occurred.

Percentages of deaths with a cause of death pending further investigation and a note on historical completeness (e.g. if the percent completeness was under 90% after 6 months) are included to aid in interpretation of provisional data as these measures are related to the accuracy of provisional counts (see Technical Notes). Counts between 1-9 are suppressed in accordance with NCHS confidentiality standards. Provisional data presented on this page will be updated on a quarterly basis as additional records are received.

Technical Notes

Nature and Sources of Data

Provisional drug overdose death counts are based on death records received and processed by the National Center for Health Statistics (NCHS) as of a specified cutoff date. The cutoff date is generally the first Sunday of each month. National provisional estimates include deaths occurring within the 50 states and the District of Columbia. NCHS receives the death records from the state vital registration offices through the Vital Statistics Cooperative Program (VSCP).

The timeliness of provisional mortality surveillance data in the National Vital Statistics System (NVSS) database varies by cause of death and jurisdiction in which the death occurred. The lag time (i.e., the time between when the death occurred and when the data are available for analysis) is longer for drug overdose deaths compared with other causes of death due to the time often needed to investigate these deaths (1). Thus, provisional estimates of drug overdose deaths are reported 6 months after the date of death.

Provisional death counts presented in this data visualization are for “12 month-ending periods,” defined as the number of deaths occurring in the 12 month period ending in the month indicated. For example, the 12 month-ending period in June 2020 would include deaths occurring from July 1, 2019 through June 30, 2020. The 12 month-ending period counts include all seasons of the year and are insensitive to reporting variations by seasonality. These provisional counts of drug overdose deaths and related data quality metrics are provided for public health surveillance and monitoring of emerging trends. Provisional drug overdose death data are often incomplete, and the degree of completeness varies by jurisdiction and 12 month-ending period. Consequently, the numbers of drug overdose deaths are underestimated based on provisional data relative to final data and are subject to random variation.

Cause of Death Classification and Definition of Drug Deaths

Mortality statistics are compiled in accordance with the World Health Organizations (WHO) regulations specifying that WHO member nations classify and code causes of death with the current revision of the International Statistical Classification of Diseases and Related Health Problems (ICD). ICD provides the basic guidance used in virtually all countries to code and classify causes of death. It provides not only disease, injury, and poisoning categories but also the rules used to select the single underlying cause of death for tabulation from the several diagnoses that may be reported on a single death certificate, as well as definitions, tabulation lists, the format of the death certificate, and regulations on use of the classification. Causes of death for data presented on this report were coded according to ICD guidelines described in annual issues of Part 2a of the NCHS Instruction Manual (2). Drug overdose deaths are identified using underlying cause-of-death codes from the Tenth Revision of ICD (ICD–10): X40–X44 (unintentional), X60–X64 (suicide), X85 (homicide), and Y10–Y14 (undetermined).

Selection of Specific Jurisdictions to Report

Provisional counts are presented by the jurisdiction where the decedent resides (e.g. county of residence). Data quality and timeliness for drug overdose deaths vary by reporting jurisdiction. Provisional counts are presented, along with measures of data quality: the percentage of records where the manner of death is listed as “pending investigation”, and a note for specific jurisdictions with historically lower levels of data completeness (where provisional 2019 data were less than 90% complete after 6 months).

Percentage of Records Pending Investigation

Drug overdose deaths often require lengthy investigations, and death certificates may be initially filed with a manner of death “pending investigation” and/or with a preliminary or unknown cause of death. When the percentage of records reported as “pending investigation” is high for a given jurisdiction, the number of drug overdose deaths is likely to be underestimated. Counts of drug overdose deaths may be underestimated to a greater extent in jurisdictions or counties where more records in NVSS are reported as “pending investigation” for the six most recent 12 month-ending periods.

Historical Completeness

The historical percent completeness of provisional data is obtained by dividing the number of death records in the NVSS database for each jurisdiction and county after a 6-month lag for deaths occurring in 2019 by the number of deaths eventually included in the final data files. Counties with historically lower levels of provisional data completeness are flagged with a note to indicate that the data may be incomplete in these areas. However, the completeness of provisional data may change over time, and therefore the degree of underestimation will not be known until data are finalized (typically 11-12 months after the end of the data year).

Differences between Final and Provisional Data

There may be differences between provisional and final data for a given data year (e.g., 2020). Final drug overdose death data published annually through NCHS statistical reports (3) and CDC WONDER undergo additional data quality checks and processing. Provisional counts reported here are subject to change as additional data are received.

Source

NCHS, National Vital Statistics System. Estimates for 2020 and 2021 are based on provisional data. Estimates for 2019 are based on final data (available from: https://www.cdc.gov/nchs/nvss/mortality_public_use_data.htm).

References

1. Spencer MR, Ahmad F. Timeliness of death certificate data for mortality surveillance and provisional estimates. National Center for Health Statistics. 2016. Available from: https://www.cdc.gov/nchs/data/vsrr/report001.pdf
2. National Vital Statistics System. Instructions for classifying the underlying cause of death. In: NCHS instruction manual; Part 2a. Published annually.
3. Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2018. NCHS Data Brief, no 356. Hyattsville, MD: National Center for Health Statistics. 2020. Available from: https://www.cdc.gov/nchs/products/databriefs/db356.htm

Suggested Citation

Ahmad FB, Anderson RN, Cisewski JA, Rossen LM, Warner M, Sutton P. County-level provisional drug overdose death counts. National Center for Health Statistics. 2021.

Designed by MirLogic Solutions Corp: National Center for Health Statistics.

Number of deaths and age-specific mortality rates for selected grouped causes, by age group and sex, 2000 to most recent year.

This data contains provisional counts for drug overdose deaths based on a current flow of mortality data in the National Vital Statistics System. Counts for the most recent final annual data are provided for comparison. National provisional counts include deaths occurring within the 50 states and the District of Columbia as of the date specified and may not include all deaths that occurred during a given time period. Provisional counts are often incomplete and causes of death may be pending investigation (see Technical notes) resulting in an underestimate relative to final counts. To address this, methods were developed to adjust provisional counts for reporting delays by generating a set of predicted provisional counts (see Technical notes). Starting in June 2018, this monthly data release will include both reported and predicted provisional counts.

The provisional data include: (a) the reported and predicted provisional counts of deaths due to drug overdose occurring nationally and in each jurisdiction; (b) the percentage changes in provisional drug overdose deaths for the current 12 month-ending period compared with the 12-month period ending in the same month of the previous year, by jurisdiction; and (c) the reported and predicted provisional counts of drug overdose deaths involving specific drugs or drug classes occurring nationally and in selected jurisdictions. The reported and predicted provisional counts represent the numbers of deaths due to drug overdose occurring in the 12-month periods ending in the month indicated. These counts include all seasons of the year and are insensitive to variations by seasonality. Deaths are reported by the jurisdiction in which the death occurred.

Several data quality metrics, including the percent completeness in overall death reporting, percentage of deaths with cause of death pending further investigation, and the percentage of drug overdose deaths with specific drugs or drug classes reported are included to aid in interpretation of provisional data as these measures are related to the accuracy of provisional counts (see Technical notes). Reporting of the specific drugs and drug classes involved in drug overdose deaths varies by jurisdiction, and comparisons of death rates involving specific drugs across selected jurisdictions should not be made (see Technical notes). Provisional data will be updated on a monthly basis as additional records are received.

Technical notes

Nature and sources of data

Provisional drug overdose death counts are based on death records received and processed by the National Center for Health Statistics (NCHS) as of a specified cutoff date. The cutoff date is generally the first Sunday of each month. National provisional estimates include deaths occurring within the 50 states and the District of Columbia. NCHS receives the death records from state vital registration offices through the Vital Statistics Cooperative Program (VSCP).

The timeliness of provisional mortality surveillance data in the National Vital Statistics System (NVSS) database varies by cause of death. The lag time (i.e., the time between when the death occurred and when the data are available for analysis) is longer for drug overdose deaths compared with other causes of death (1). Thus, provisional estimates of drug overdose deaths are reported 6 months after the date of death.

Provisional death counts presented in this data visualization are for “12-month ending periods,” defined as the number of deaths occurring in the 12-month period ending in the month indicated. For example, the 12-month ending period in June 2017 would include deaths occurring from July 1, 2016, through June 30, 2017. The 12-month ending period counts include all seasons of the year and are insensitive to reporting variations by seasonality. Counts for the 12-month period ending in the same month of the previous year are shown for comparison. These provisional counts of drug overdose deaths and related data quality metrics are provided for public health surveillance and monitoring of emerging trends. Provisional drug overdose death data are often incomplete, and the degree of completeness varies by jurisdiction and 12-month ending period. Consequently, the numbers of drug overdose deaths are underestimated based on provisional data relative to final data and are subject to random variation. Methods to adjust provisional counts have been developed to provide predicted provisional counts of drug overdose deaths, accounting for delayed reporting (see Percentage of records pending investigation and Adjustments for delayed reporting).

Provisional data are based on available records that meet certain data quality criteria at the time of analysis and may not include all deaths that occurred during a given time period. Therefore, they should not be considered comparable with final data and are subject to change.

Cause-of-death classification and definition of drug deaths
Mortality statistics are compiled in accordance with World Health Organization (WHO) regulations specifying that WHO member nations classify and code causes of death with the current revision of the International Statistical Classification of Diseases and Related Health Problems (ICD). ICD provides the basic guidance used in virtually all countries to code and classify causes of death. It provides not only disease, injury, and poisoning categories but also the rules used to select the single underlying cause of death for tabulation from the several diagnoses that may be reported on a single death certificate, as well as definitions, tabulation lists, the format of the death certificate, and regulations on use of the classification. Causes of death for data presented in this report were coded according to ICD guidelines described in annual issues of Part 2a of the NCHS Instruction Manual (2).

Drug overdose deaths are identified using underlying cause-of-death codes from the Tenth Revision of ICD (ICD–10): X40–X44 (unintentional), X60–X64 (suicide), X85 (homicide), and Y10–Y14 (undetermined). Drug overdose deaths involving selected drug categories are identified by specific multiple cause-of-death codes. Drug categories presented include: heroin (T40.1); natural opioid analgesics, including morphine and codeine, and semisynthetic opioids, including drugs such as oxycodone, hydrocodone, hydromorphone, and oxymorphone (T40.2); methadone, a synthetic opioid (T40.3); synthetic opioid analgesics other than methadone, including drugs such as fentanyl and tramadol (T40.4); cocaine (T40.5); and psychostimulants with abuse potential, which includes methamphetamine (T43.6). Opioid overdose deaths are identified by the presence of any of the following MCOD codes: opium (T40.0); heroin (T40.1); natural opioid analgesics (T40.2); methadone (T40.3); synthetic opioid analgesics other than methadone (T40.4); or other and unspecified narcotics (T40.6). This latter category includes drug overdose deaths where ‘opioid’ is reported without more specific information to assign a more specific ICD–10 code (T40.0–T40.4) (3,4). Among deaths with an underlying cause of drug overdose, the percentage with at least one drug or drug class specified is defined as that with at least one ICD–10 multiple cause-of-death code in the range T36–T50.8.

Drug overdose deaths may involve multiple drugs; therefore, a single death might be included in more than one category when describing the number of drug overdose deaths involving specific drugs. For example, a death that involved both heroin and fentanyl would be included in both the number of drug overdose deaths involving heroin and the number of drug overdose deaths involving synthetic opioids other than methadone.

Selection of specific states and other jurisdictions to report
Provisional counts are presented by the jurisdiction in which the death occurred (i.e., the reporting jurisdiction). Data quality and timeliness for drug overdose deaths vary by reporting jurisdiction. Provisional counts are presented for reporting jurisdictions based on measures of data quality: the percentage of records where the manner of death is listed as “pending investigation,” the overall completeness of the data, and the percentage of drug overdose death records with specific drugs or drug classes recorded. These criteria are defined below.

Percentage of records pending investigation

Drug overdose deaths often require lengthy investigations, and death certificates may be initially filed with a manner of death “pending investigation” and/or with a preliminary or unknown cause of death. When the percentage of records reported as “pending investigation” is high for a given jurisdiction, the number of drug overdose deaths is likely to be underestimated. For jurisdictions reporting fewer than 1% of records as “pending investigation”, the provisional number of drug overdose deaths occurring in the fourth quarter of 2015 was approximately 5% lower than the final count of drug overdose deaths occurring in that same time period. For jurisdictions reporting greater than 1% of records as “pending investigation” the provisional counts of drug overdose deaths may underestimate the final count of drug overdose deaths by as much as 30%. Thus, jurisdictions are included in Table 2 if 1% or fewer of their records in NVSS are reported as “pending investigation,” following a 6-month lag for the 12-month ending periods included in the dashboard. Values for records pending investigation are updated with each monthly release and reflect the most current data available.

Percent completeness

NCHS receives monthly counts of the estimated number of deaths from each jurisdictional vital registration offices (referred to as “control counts”). This number represents the best estimate of how many

In 2023, non-Hispanic Black women had the highest rates of maternal mortality among select races/ethnicities in the United States, with 50.3 deaths per 100,000 live births. The total maternal mortality rate in the U.S. at that time was 18.6 per 100,000 live births, a decrease from a rate of almost 33 in 2021. This statistic presents the maternal mortality rates in the United States from 2018 to 2023, by race and ethnicity.

The data provides the number of deaths in 2018. The data sheet includes 2 columns: "Area", "Number_of_deaths”, showing the region and number of deaths, respectively

The North Carolina State Center for Health Services (SCHS) collects yearly vital statistics. The Odum Institute holds vital statistics beginning in 1968 for deaths, marriages and divorce. Public marriage and divorce data are available through 1999 only. Vital statistics for births, fetal deaths, and birth/infant deaths may be obtained directly from SCHS by submitting a request to SCHS.Info@dhhs.nc.gov This study focuses on deaths in North Carolina in 2018. Death is defined as the permanent disappearance of any evidence of life at any time after live birth. This definition excludes fetal deaths. The data kept for deaths includes the age, race, marital status, and sex of the individual; date, time, cause and location of death; and mode of burial. Minor changes to the files beginning in 2014 reflect the release of an updated NC Death Certificate form in that year. The data are strictly numerical; there is no identifying information given about the individuals.

In 2023, about **** million deaths were reported in the United States. This figure is an increase from **** million deaths reported in 1990, and from **** in 2019. This sudden increase can be attributed to the COVID-19 pandemic.

United States Excess Deaths excl COVID: Predicted: Avg No. of Deaths: Maine data was reported at 313.000 Number in 08 Jan 2022. This stayed constant from the previous number of 313.000 Number for 01 Jan 2022. United States Excess Deaths excl COVID: Predicted: Avg No. of Deaths: Maine data is updated weekly, averaging 291.500 Number from Jan 2017 to 08 Jan 2022, with 262 observations. The data reached an all-time high of 317.000 Number in 16 Mar 2019 and a record low of 266.000 Number in 18 Aug 2018. United States Excess Deaths excl COVID: Predicted: Avg No. of Deaths: Maine data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G014: Number of Excess Deaths: by States: All Causes excluding COVID-19: Predicted.

This dataset includes the count and rate per 100,000 Virginia residents of injury deaths among Virginia residents, only whether or not they died in state. City/county is based on the place of residence at time of death. Deaths are counted from vital records death certificate data. Data set includes injury death counts and rates for years 2018 through the most recent data year available. When data set is downloaded, the years will be sorted in ascending order, meaning that the earliest year will be at the top. To see data for the most recent year, please scroll down to the bottom of the data set.

Monaco: Death rate, per 1000 people: The latest value from 2018 is 6.6 deaths per 1000 people, a decline from 7.9 deaths per 1000 people in 2016. In comparison, the world average is 7.63 deaths per 1000 people, based on data from 196 countries. Historically, the average for Monaco from 2004 to 2018 is 9.5 deaths per 1000 people. The minimum value, 6.6 deaths per 1000 people, was reached in 2018 while the maximum of 15.9 deaths per 1000 people was recorded in 2004.

【リソース】Volume 1_5-1_Trends in deaths, death rates (per 1,000 population) by sex and sex ratio:Japan / Volume 1_5-2_Trends in crude death rates and age-adjusted death rates (per 1,000 population) by sex:Japan / Volume 1_5-4_Trends in deaths and death rates (per 1,000 population) by month:Japan / Volume 1_5-5_Trends in deaths by place of occurrence:Japan / Volume 1_5-6_Trends in percent distribution of deaths by place of occurrence:Japan / Volume 1_5-7_Deaths by place of occurrence:Japan, each prefecture and 21 major cities, 2018 / Volume 1_5-8_Percent distribution of deaths by place of occurrence:Japan, each prefecture and 21 major cities, 2018 / Volume 1_5-9_Trends in deaths by each prefecture:Japan / Volume 1_5-10_Trends in death rates (per 1,000 population) by each prefecture:Japan / Volume 1_5-11_Trends in leading causes of death:Japan (Death rates (per 100,000 population)) / Volume 1_5-12_Trends in deaths and death rates (per 100,000 population) by sex and causes of death:Japan / Volume 1_5-13_Trends in deaths and death rates (per 100,000 population) by sex and causes (the condensed list of causes of death for Japan):Japan / Volume 1_5-14_Trends in age-adjusted death rates (per 100,000 population) by sex and causes of death:Japan / Volume 1_5-15_Trends in deaths and death rates (per 100,000 population) by sex, age and causes of death:Japan / Volume 1_5-16_Death rates (per 100,000 population) by sex, age and causes (the condensed list of causes of death for Japan):Japan, 2018 / Volume 1_5-17_Leading causes of death by sex and age:Japan, 2018 (deaths, death rates (per 100,000 population), proportion(%)) / Volume 1_5-18_Death rates (per 100,000 population) by causes (the condensed list of causes of death for Japan) by month:Japan, 2018 / Volume 1_5-19_Death rates (per 100,000 population) by causes (the condensed list of causes of death for Japan):Japan, each prefecture and 21 major cities, 2018 / Volume 1_5-20_Leading causes of death:Japan, each prefecture and 21 major cities, 2018 / Volume 1_5-21_Trends in deaths and percent distribution from leading causes of death by sex and place of occurrence:Japan / Volume 1_5-22_Deaths and percent distribution from leading causes of death by sex, age and place of occurrence:Japan, 2018 / Volume 1_5-23_Deaths and percent distribution by causes (the selected list of causes of death for Japan) and type of occupation of household:Japan, 2018 / Volume 1_5-24_Trends in deaths and death rates (per 100,000 population) from malignant neoplasms by sex and site:Japan / Volume 1_5-25_Trends in death rates (per 100,000 population) from malignant neoplasms by sex, age and site:Japan / Volume 1_5-26_Trends in age-adjusted death rates (per 100,000 population) from malignant neoplasms by sex and site:Japan / Volume 1_5-27_Trends in deaths, percent distribution, crude death rates and age-adjusted death rates (per 100,000 population) from cerebrovascular diseases by sex and disease type:Japan / Volume 1_5-28_Trends in deaths, percent distribution, crude death rates and age-adjusted death rates (per 100,000 population) from heart diseases by sex and disease type:Japan / Volume 1_5-29_Trends in deaths and death rates (per 100,000 population) by causes (the list of infectious diseases):Japan / Volume 1_5-30_Trends in deaths and death rates (per 100,000 population) from accidents by external causes:Japan / Volume 1_5-31_Deaths from accidents by age and external causes:Japan, 2018 / Volume 1_5-32_Percent distribution of deaths from accidents by age and external causes:Japan, 2018 / Volume 1_5-33_Trends in deaths and percent distribution from transportation accidents by external causes:Japan / Volume 1_5-34_Deaths and percent distribution from nontransportation accidents by age and place of occurrence:Japan, 2018 / Volume 1_5-35_Deaths and percent distribution from accidents at home by age and external causes:Japan, 2018 / Volume 1_5-36_Trends in deaths and percent distribution from suicide by sex and external causes:Japan / Volume 1_5-37_Trends in maternal deaths and maternal mortality rates (per 100,000 total births) by causes of death:Japan / Volume 1_5-38_Trends in late maternal deaths and late maternal mortality rates (per 100,000 total births) by causes of death:Japan / Volume 1_5-39_Trends in maternal deaths and maternal mortality rates (per 100,000 total births) by each prefecture:Japan / Volume 2_1_Deaths, infant deaths (under 1 year), neonatal deaths (under 4 weeks) and early neonatal deaths (under 1 week), by place of occurrence, for urban/rural residence:Japan, each prefecture and 21 major cities / Volume 2_2_Deaths by sex and month of occurrence:Japan, urban/rural residence, each prefecture and 21 major cities / Volume 2_3_Deaths by sex and age:Japan, each prefecture and 21 major cities / Volume 2_4_Deaths by sex and single years of age:Japan, each prefecture and 21 major cities_(1) Total,0-64years / Volume 2_4_Deaths by sex and single years of age:Japan, each prefecture and 21